Bo Cumbo
Vermogen: 1 M $ op 31-10-2026
Vermogen: 1 M $ op 31-10-2026
Alexander Gery Cumbo is President, Chief Executive Officer & Director at Solid Biosciences, Inc. since 2022.
Mr. Cumbo serves as Independent Director at Vor Biopharma, Inc. starting in 2025.
Mr. Cumbo serves as Independent Director at Climb Bio, Inc. starting in 2025.
Mr. Cumbo serves as Director at Stoke Therapeutics, Inc. starting in 2026.
Former roles include President, Chief Executive Officer & Director at AavantiBio, Inc. from 2020 to 2022.
Independent Director at Ra Pharmaceuticals, Inc. from 2018 to 2020.
Director at Clinical Supplies Management, Inc. from 2012 to 2017.
Independent Director at Verve Therapeutics, Inc. from 2022 to 2025.
Vice President-Sales & Treatment Education at Vertex Pharmaceuticals, Inc. from 2010 to 2013.
Senior VP-Global Commercial Development at Sarepta Therapeutics, Inc. from 2013 to 2016.
Education includes an undergraduate degree from Auburn University conferred in 1994.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 235.405 ( 0,21% ) | 1 M $ | 31-10-2026 | |
CLIMB BIO, INC. -.--% | 05-06-2026 | 0 ( -.--% ) | - $ | 31-10-2026 |
VOR BIOPHARMA, INC. -.--% | 11-06-2026 | 0 ( -.--% ) | - $ | 31-10-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SOLID BIOSCIENCES INC. | Algemeen Directeur | 02-12-2022 |
| CLIMB BIO, INC. | Directeur/Bestuurslid | 28-03-2025 |
| VOR BIOPHARMA INC. | Directeur/Bestuurslid | 16-07-2025 |
| STOKE THERAPEUTICS, INC. | Directeur/Bestuurslid | 23-09-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| VERE THER | Directeur/Bestuurslid | 25-07-2025 |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Algemeen Directeur | 01-12-2022 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-10-2020 |
| RA PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 02-04-2020 |
Clinical Supplies Management, Inc.
Clinical Supplies Management, Inc. Medical/Nursing ServicesHealth Services Offers clinical trial services to biotechnology and pharmaceutical companies | Directeur/Bestuurslid | 01-01-2017 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 11 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
Auburn University
Auburn University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clinical Supplies Management, Inc.
Clinical Supplies Management, Inc. Medical/Nursing ServicesHealth Services Offers clinical trial services to biotechnology and pharmaceutical companies | Health Services |
Solid Biosciences, Inc.
Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Vor Biopharma, Inc.
Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Verve Therapeutics, Inc.
Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau